WebDec 31, 2024 · Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The … WebNov 18, 2024 · For example, long term Bioventix PLC shareholders have enjoyed a 42% share price rise over the last half decade, well in excess of the market decline of around 7.5% (not including dividends). On ...
BIOVENTIX PLC : Shareholders Board Members Managers …
WebBioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual Report and Accounts for the year ended 30 June 2024 and the Notice of Annual General Meeting (“AGM”) has been posted to shareholders. A PDF version of … WebApr 11, 2024 · Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. crystal glass survey
Bioventix Plc - Half-year Report MarketScreener
WebMar 27, 2024 · Overview. Welcome current and prospective investors. On this page, you will find relevant news, detailed financial reports, and links to useful tools regarding Bioventix plc. This site contains key corporate, financial and shareholder information for … Bioventix plc (“Bioventix” or the “Company”) Result of AGM Bioventix plc (AIM: … WebMar 29, 2024 · Bioventix is not owned by hedge funds. Castlefield Investment Partners LLP is currently the largest shareholder, with 20% of shares outstanding. Liontrust Asset … WebFeb 26, 2024 · Shareholders would probably be interested to learn that insiders own shares in Bioventix PLC. In their own names, insiders own UK£14m worth of stock in the UK£200m company. crystal glass \\u0026 metals inc